APA (7th ed.) Citation

MB, O., K, S., R, P., P, L., J, R. A., U, B., . . . M, J. (2026). Safety and Efficacy of HexaBody-DR5/DR5 in Malignant Solid Tumors: Phase 1/2a Results and Translational Insights Into Observed Hepatotoxicity. Clinical and translational science, 19(6), e70546. https://doi.org/10.1111/cts.70546

Chicago Style (17th ed.) Citation

MB, Overdijk, et al. "Safety and Efficacy of HexaBody-DR5/DR5 in Malignant Solid Tumors: Phase 1/2a Results and Translational Insights Into Observed Hepatotoxicity." Clinical and Translational Science 19, no. 6 (2026): e70546. https://doi.org/10.1111/cts.70546.

MLA (9th ed.) Citation

MB, Overdijk, et al. "Safety and Efficacy of HexaBody-DR5/DR5 in Malignant Solid Tumors: Phase 1/2a Results and Translational Insights Into Observed Hepatotoxicity." Clinical and Translational Science, vol. 19, no. 6, 2026, p. e70546, https://doi.org/10.1111/cts.70546.